BYSI
BEYONDSPRING (BYSI) Files 8-K on Nasdaq Listing Compliance Issue
The clinical-stage biotech filed an Item 3.01 disclosure covering a delisting notice or failure to meet a continued listing standard.
BYSI
Market-moving news on BeyondSpring (NASDAQ: BYSI): filings, earnings, deals and other events, from REDFILED.